{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:58:09Z","timestamp":1793210289790,"version":"4.5.0"},"reference-count":77,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.19151","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T15:33:57Z","timestamp":1628868837000},"page":"e2119151","source":"Crossref","is-referenced-by-count":71,"title":["Comparison of Antiviral Agents for Seasonal Influenza Outcomes in Healthy Adults and Children"],"prefix":"10.1001","volume":"4","author":[{"given":"Jen-Wei","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan"},{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Hua","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Chien","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Yean","family":"Chiu","sequence":"additional","affiliation":[{"name":"School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan"},{"name":"Research Center of Sleep Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Ai","family":"Lee","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"issue":"10","key":"zoi210575r2","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1001\/jama.2020.15260","article-title":"What happens when COVID-19 collides with flu season?","volume":"324","author":"Rubin","year":"2020","journal-title":"JAMA"},{"issue":"13","key":"zoi210575r3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.","volume":"282","author":"Hayden","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"zoi210575r4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40265-018-0899-1","article-title":"Baloxavir: First Global Approval.","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"issue":"6","key":"zoi210575r5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi210575r8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis.","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"1","key":"zoi210575r9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"zoi210575r10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents.","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi210575r11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","article-title":"Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.","volume":"20","author":"Ison","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"24","key":"zoi210575r12","first-page":"2132","article-title":"A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients.","volume":"84","author":"Deng","year":"2004","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"8","key":"zoi210575r13","first-page":"560","article-title":"A randomized controlled study of peramivir, oseltamivir and placebo in patients with mild influenza.","volume":"58","author":"Fan","year":"2019","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"2","key":"zoi210575r14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S1473-3099(13)70267-6","article-title":"Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.","volume":"14","author":"Fry","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"zoi210575r15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections: GG167 Influenza Study Group.","volume":"337","author":"Hayden","year":"1997","journal-title":"N Engl J Med"},{"issue":"18","key":"zoi210575r16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1056\/NEJM200011023431801","article-title":"Inhaled zanamivir for the prevention of influenza in families.","volume":"343","author":"Hayden","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi210575r17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00006454-200005000-00005","article-title":"Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.","volume":"19","author":"Hedrick","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"zoi210575r18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1086\/652982","article-title":"Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial.","volume":"51","author":"Heinonen","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"12","key":"zoi210575r19","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1093\/cid\/ciu632","article-title":"Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients.","volume":"59","author":"de Jong","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"zoi210575r20","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.11150\/kansenshogakuzasshi1970.74.1044","article-title":"Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza\u2014placebo-controlled double-blind multicenter phase III trial.","volume":"74","author":"Kashiwagi","year":"2000","journal-title":"Kansenshogaku Zasshi"},{"issue":"11","key":"zoi210575r21","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1128\/AAC.00474-10","article-title":"Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection.","volume":"54","author":"Kohno","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"zoi210575r22","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1128\/AAC.01718-10","article-title":"Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients.","volume":"55","author":"Kohno","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"zoi210575r23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3901\/JME.2003.06.044","article-title":"A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China.","volume":"116","author":"Li","year":"2003","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"zoi210575r24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1185\/030079906X80297","article-title":"A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population.","volume":"22","author":"Lin","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"zoi210575r25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/jinf.1999.0602","article-title":"Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.","volume":"40","author":"M\u00e4kel\u00e4","year":"2000","journal-title":"J Infect"},{"issue":"9144","key":"zoi210575r26","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0140-6736(98)10190-3","article-title":"Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections.","volume":"352","author":"The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group","year":"1998","journal-title":"Lancet"},{"key":"zoi210575r27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/jac\/44.suppl_2.23","article-title":"Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis.","volume":"44","author":"Monto","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"zoi210575r28","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx129","article-title":"Efficacy and safety of intravenous peramivir compared with oseltamivir in high-risk patients infected with influenza a and b viruses: a multicenter randomized controlled study.","volume":"4","author":"Nakamura","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"9218","key":"zoi210575r29","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial.","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"zoi210575r30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/0036554021000026981","article-title":"Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza.","volume":"35","author":"Puhakka","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"zoi210575r31","doi-asserted-by":"publisher","first-page":"f3039","DOI":"10.1136\/bmj.f3039","article-title":"Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial.","volume":"346","author":"South East Asia Infectious Disease Clinical Research Network","year":"2013","journal-title":"BMJ"},{"issue":"8","key":"zoi210575r32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial.","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"key":"zoi210575r33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.antiviral.2019.01.012","article-title":"Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type\/subtype outcomes from a randomized phase 2 study.","volume":"163","author":"Watanabe","year":"2019","journal-title":"Antiviral Res"},{"issue":"2","key":"zoi210575r34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children.","volume":"20","author":"Whitley","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"zoi210575r35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3851\/IMP2874","article-title":"Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials.","volume":"20","author":"Whitley","year":"2015","journal-title":"Antivir Ther"},{"issue":"4","key":"zoi210575r36","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1086\/jid.2000.181.issue-4","article-title":"Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults.","volume":"181","author":"Boivin","year":"2000","journal-title":"J Infect Dis"},{"issue":"5","key":"zoi210575r37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3851\/IMP2442","article-title":"A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.","volume":"18","author":"Ison","year":"2013","journal-title":"Antivir Ther"},{"issue":"6","key":"zoi210575r38","doi-asserted-by":"publisher","first-page":"e1431","DOI":"10.1542\/peds.2011-2054","article-title":"Effect of a single inhalation of laninamivir octanoate in children with influenza.","volume":"129","author":"Katsumi","year":"2012","journal-title":"Pediatrics"},{"issue":"4","key":"zoi210575r39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3851\/IMP2680","article-title":"Intravenous peramivir for treatment of influenza in hospitalized patients.","volume":"19","author":"Ison","year":"2014","journal-title":"Antivir Ther"},{"issue":"2","key":"zoi210575r40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/135965359900400202","article-title":"Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.","volume":"4","author":"Matsumoto","year":"1999","journal-title":"Antivir Ther"},{"issue":"6","key":"zoi210575r41","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1128\/AAC.01755-09","article-title":"Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection.","volume":"54","author":"Sugaya","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"zoi210575r42","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1086\/652984","article-title":"Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial.","volume":"51","author":"Watanabe","year":"2010","journal-title":"Clin Infect Dis"},{"key":"zoi210575r43","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"zoi210575r44","doi-asserted-by":"publisher","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"zoi210575r45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis.","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"zoi210575r46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis.","volume":"9","author":"Salanti","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"zoi210575r48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2288-7-5","article-title":"Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data.","volume":"7","author":"Friedrich","year":"2007","journal-title":"BMC Med Res Methodol"},{"issue":"16","key":"zoi210575r49","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/sim.v38.16","article-title":"Network meta-analysis of rare events using the Mantel-Haenszel method.","volume":"38","author":"Efthimiou","year":"2019","journal-title":"Stat Med"},{"issue":"10","key":"zoi210575r50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA.","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"zoi210575r51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods.","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"zoi210575r52","doi-asserted-by":"crossref","first-page":"l6483","DOI":"10.1136\/bmj.l6483","article-title":"Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis.","volume":"367","author":"Eusebi","year":"2019","journal-title":"BMJ"},{"issue":"21","key":"zoi210575r53","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1002\/sim.v33.21","article-title":"A design-by-treatment interaction model for network meta-analysis with random inconsistency effects.","volume":"33","author":"Jackson","year":"2014","journal-title":"Stat Med"},{"issue":"2","key":"zoi210575r54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jrsm.v3.2","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies.","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods"},{"issue":"7-8","key":"zoi210575r55","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis.","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"issue":"474","key":"zoi210575r56","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons.","volume":"101","author":"Lu","year":"2006","journal-title":"J Am Stat Assoc"},{"key":"zoi210575r57","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"zoi210575r58","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/cid\/ciy163","article-title":"A randomized study evaluating the effectiveness of oseltamivir initiated at the time of hospital admission in adults hospitalized with influenza-associated lower respiratory tract infections.","volume":"67","author":"Ramirez","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"zoi210575r59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/14787210.2018.1421945","article-title":"Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan.","volume":"16","author":"Hirotsu","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"zoi210575r60","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S1473-3099(17)30476-0","article-title":"Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.","volume":"17","author":"Beigel","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"zoi210575r61","first-page":"462","article-title":"Efficacy and safety of oseltamivir in children with suspected influenza: a multicenter randomized open-label trial.","volume":"55","author":"He","year":"2017","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"5","key":"zoi210575r62","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/23744235.2016.1242773","article-title":"Clinical efficacy of laninamivir and peramivir in patients with seasonal influenza: a randomized clinical trial.","volume":"49","author":"Yoshino","year":"2017","journal-title":"Infect Dis (Lond)"},{"key":"zoi210575r63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.antiviral.2016.07.007","article-title":"A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama.","volume":"133","author":"Dawood","year":"2016","journal-title":"Antiviral Res"},{"issue":"1","key":"zoi210575r64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10156-012-0460-1","article-title":"A randomized double-blind controlled study of laninamivir compared with oseltamivir for the treatment of influenza in patients with chronic respiratory diseases.","volume":"19","author":"Watanabe","year":"2013","journal-title":"J Infect Chemother"},{"issue":"11","key":"zoi210575r65","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1128\/AAC.00360-11","article-title":"Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.","volume":"55","author":"Kohno","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"zoi210575r66","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jamda.2005.08.006","article-title":"Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population.","volume":"6","author":"Gravenstein","year":"2005","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"zoi210575r67","first-page":"838","article-title":"A multicenter study of efficacy and safety of oseltamivir in treatment of naturally acquired influenza.","volume":"40","author":"Li","year":"2001","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"7","key":"zoi210575r68","first-page":"455","article-title":"A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population.","volume":"27","author":"Lin","year":"2004","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"2","key":"zoi210575r69","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1086\/jid.1999.180.issue-2","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.","volume":"180","author":"Monto","year":"1999","journal-title":"J Infect Dis"},{"issue":"18","key":"zoi210575r70","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0264-410X(98)00141-8","article-title":"Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks.","volume":"16","author":"Schilling","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"zoi210575r71","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1080\/03007995.2019.1584505","article-title":"A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients.","volume":"35","author":"Taieb","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"zoi210575r72","article-title":"Network meta-analysis: application and practice using R software.","volume":"41","author":"Shim","year":"2019","journal-title":"Epidemiol Health"},{"issue":"11","key":"zoi210575r73","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1093\/jac\/dkx271","article-title":"Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and\/or meta-analyses.","volume":"72","author":"Doll","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"zoi210575r74","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.","volume":"2014","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"9979","key":"zoi210575r75","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.","volume":"385","author":"Dobson","year":"2015","journal-title":"Lancet"},{"key":"zoi210575r76","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/irv.12085","article-title":"Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies.","volume":"7","author":"Santesso","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"7","key":"zoi210575r77","doi-asserted-by":"publisher","first-page":"512","DOI":"10.7326\/0003-4819-156-7-201204030-00411","article-title":"Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.","volume":"156","author":"Hsu","year":"2012","journal-title":"Ann Intern Med"},{"key":"zoi210575r7","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.1","author":"Higgins","year":"2020"},{"key":"zoi210575r1","unstructured":"Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Accessed December 20, 2020. https:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm"},{"key":"zoi210575r6","unstructured":"Centers for Disease Control and Prevention. What you should know about flu antiviral drugs. Accessed December 20, 2020. https:\/\/www.cdc.gov\/flu\/treatment\/whatyoushould.htm"},{"key":"zoi210575r47","unstructured":"R\u00fccker? G, Krahn? U, K\u00f6nig? J, Efthimiou? O, Schwarzer? G. Netmeta: network meta-analysis using frequentist methods. Version 1.3-0. CRAN.R Project. Accessed June 15, 2019. https:\/\/cran.r-project.org\/web\/packages\/netmeta\/index.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2782995\/liu_2021_oi_210575_1632931967.93312.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T10:01:57Z","timestamp":1673085717000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2782995"}},"subtitle":["A Systematic Review and Network Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.19151","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]}}}